GSK 241213 34.00P (GSK241213P34000) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

GSK241213P34000

Watchlist

0.05
-0.09-64.29%

15min DelayClose Dec 13 16:00 ET

0.25High0.04Low

Intraday

5D
Daily

News

United Kingdom's National Health Service Drug Spending Priorities Questioned in New Analysis
BenzingaDec 13 11:06 ET
Gilead Unveils New Yearly HIV Injection To Offer Hope for Less Frequent Preventive Dosing
BenzingaDec 12 13:13 ET
Barclays Remains a Hold on GlaxoSmithKline (GSK)
TipRanksDec 12 02:35 ET · Ratings
Top Gap Ups and Downs on Wednesday: MLI, MSTR, GSK and More
Moomoo NewsDec 11 18:00 ET · Markets
Anaptys Scraps Development of ANB032, Stock Plunges 33%
Seeking AlphaDec 11 11:52 ET
TD Cowen Maintains GlaxoSmithKline(GSK.US) With Hold Rating, Maintains Target Price $45
Moomoo NewsDec 11 10:32 ET · Ratings

Comments

corbotron

Oct 10 09:25

I hope these bullies get decimated

$Pfizer (PFE.US)$ destroyed the shareholder confidence again. company isn't interested in shareholder value. latest threat of legal action against the former executives shows the company has no intention of curbing their careless cash spend. it's gone from creating value for shareholders to taking value from shareholders. bullies thinking they can do what they want with no repercussions. I hope their share price gets decimated over their poor decision to use forc...

Moomoo Breakfast US

Oct 10 06:53

Columns US Morning News Call | U.S. Stock Futures Drop Ahead of Key Inflation Report; Tesla Robotaxi Event Catches Attention

Expand

Tesla's "Cybercab" global debut sends stock falling

corbotron

Oct 9 15:33

$Pfizer (PFE.US)$ another positive, keep an eye $GlaxoSmithKline (GSK.US)$ $Apple (AAPL.US)$ $

Pfizer Inc - Declares $0.42 Fourth-Quarter 2024 Dividend

corbotron

Oct 9 15:07

$Pfizer (PFE.US)$ definitely an opportunity here to catch the rise, CEO will be meeting next week with new investor. discussions on directions will most likely be on the table and trimming the fat of recent acquisitions. speculation is making this stock rise until the news from the meeting is released. it's looking like there is more in the rumor mill and the price is reflecting it over the last couple sessions. keep an eye $Apple (AAPL.US)$ $Novo-Nordisk A/S (NVO.US)$ $GlaxoSmithKline (GSK.US)$

corbotron

Oct 9 12:29

$Pfizer (PFE.US)$ could see 32$ before the end of tomorrow , keep an eye $GlaxoSmithKline (GSK.US)$ $Summit Therapeutics (SMMT.US)$ $Ascendis Pharma A/S (ASND.US)$